Charles Russell Speechlys advises Kreos Capital V (UK) Limited on senior secured loan to Pharming Group NV
Charles Russell Speechlys LLP advised Kreos Capital V (UK) Limited (“Kreos”) on its €21 million senior secured loan to Pharming Group NV (“Pharming”) and its subscription for €6 million subordinated redeemable convertible bond issued by Pharming.
The transaction is part of a larger fundraising exercise carried out by Pharming to raise €104 million before costs (comprising of straight debt, convertible bonds and proceeds of rights issue) to, amongst others, acquire all commercialisation rights to its own product RUCONEST® in North America and to repay its existing debt facility.
The Charles Russell Speechlys core team comprised Corporate Partner Chris Putt, Corporate Associates Rossana Conti and Amelly Kok and Banking Partner Daniel Sullivan.
News & Insights
Charles Russell Speechlys advises MayAir Group plc on recommended £50m+ sale to Poly Glorious Investment Co Ltd
MayAir Group plc are an AIM-listed manufacturer, developer and provider of air filtration equipment and clean air solutions.
Market Abuse Regulation Breakfast, 25 April 2018
Discussing developments and practical approaches to issues that have arisen since MAR came into force.
Charles Russell Speechlys advises discoverIE Group plc on Dutch manufacturer Santon Group
Santon is a Dutch based designer and manufacturer of custom switches for electronic applications.